Edward J III Dulac, EVP & CFO at Intellia Therapeutics, holds 148.18K shares in Intellia Therapeutics (Ticker: NTLA), holds 101.48K shares in Fate Therapeutics (Ticker: FATE). Most recently, Edward J III Dulac Sold ― shares of Intellia Therapeutics on Jul 24, 2026 for an estimated value of $91.25K.
What is the percentage of profitable transactions made by Edward J III Dulac?
The percentage of profitable transactions made by Edward J III Dulac is 67%.
What is the average return per transaction made by Edward J III Dulac?
The average return per transaction made by Edward J III Dulac is 30.70%.
What stocks does Edward J III Dulac hold?
Edward J III Dulac holds: NTLA, FATE stocks.
What was Edward J III Dulac’s latest transaction?
Edward J III Dulac latest transaction was an Informative Sell of $91.25K.
What was Edward J III Dulac's most profitable transaction?
Edward J III Dulac’s most profitable transaction was an Informative Sell of FATE stock on August 19, 2022. The return on the trade was 90.40%.
What is Edward J III Dulac's role in Intellia Therapeutics?
Edward J III Dulac's role in Intellia Therapeutics is EVP & CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.